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I N T R O D U C T I O N
KCNQ1 (Q1 or Kv7.1) voltage-gated K
+ channels are 
composed of archetypical six transmembrane (TM) sub-
units that tetramerize to form an ion-conducting pore 
domain (S5–S6) surrounded by four voltage-sensing do-
mains (S1–S4). The cytoplasmic S4–S5 linker between 
these two functionally distinct domains mechanically 
couples voltage sensing to activation gate opening and 
closing. Although homotetrameric Q1 channels gener-
ate a fast activating delayed rectifier K
+ current when ex-
pressed in standard expression systems (Barhanin et al., 
1996; Sanguinetti et al., 1996), in native tissues the chan-
nel is obligatorily coassembled with one of the five mem-
bers of the KCNE family of regulatory subunits (KCNE1-5; 
encoded proteins are MinK and MiRP1-4, respectively) 
(McCrossan and Abbott, 2004). Coassembly with these 
type I TM peptides markedly changes the voltage gat-
ing of the Q1 channel, allowing it to properly function 
in different tissues, including cardiac myocytes, co-
chlea, renal, gastrointestinal, and pulmonary epithelia 
(Barhanin et al., 1996; Sanguinetti et al., 1996; Mall et al., 
2000; Schroeder et al., 2000; Nicolas et al., 2001; Roepke 
et al., 2006). Modulation of Q1 channel function by all 
five KCNE proteins has been observed; however, Q1’s 
A. Lvov and S.D. Gage contributed equally to this paper.
Correspondence to William R. Kobertz: william.kobertz@ﾭumassmed.edu
Abbreviations used in this paper: CHO, Chinese hamster ovary; DTT, 
dithiothreitol; E1–E5, KCNE1–KCNE5; PNGase F, peptide N-glycosidase F; 
Q1, KCNQ1; TM, transmembrane.
association with KCNE1 (E1) has been studied more 
thoroughly due to the involvement of this complex in 
several pathophysiological conditions ranging from in-
herited ventricular arrhythmias (Splawski et al., 1997b) 
to deafness (Vetter et al., 1996; Tyson et al., 2000). In car-
diomyocytes, the Q1–E1 complex conducts the slowly 
activating and deactivating, yet apparently non-inacti-
vating, IKs current (Sanguinetti and Jurkiewicz, 1990; 
Barhanin et al., 1996; Sanguinetti et al., 1996), which is 
involved in the repolarization phase of cardiac action 
potential. Mutations in either Q1 (Chouabe et al., 1997; 
Napolitano et al., 2005) or E1 (Splawski et al., 1997b, 2000) 
that decrease the conductance of the complex prolong 
the cardiac action potential and cause arrhythmias, includ-
ing long QT syndrome. In the inner ear, where Q1–E1 
complex provides a passage for K
+ to the endolymph in 
the cavities of the cochlear labyrinth, these detrimental 
mutations can cause congenital deafness (Chouabe et al., 
1997; Neyroud et al., 1997; Splawski et al., 1997a).
In contrast to K
+ channel interactions with strictly 
cytoplasmic modulators, such as G proteins, KChIPs, or 
Kv subunits, the site of action of E1, a single-pass mem-
brane protein, has been sought in the extracellular,   
cytoplasmic, and membrane-embedded regions of Q1. 
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KCNQ1 channels assemble with KCNE1 transmembrane (TM) peptides to form voltage-gated K
+ channel com-
plexes with slow activation gate opening. The cytoplasmic C-terminal domain that abuts the KCNE1 TM segment 
has been implicated in regulating KCNQ1 gating, yet its interaction with KCNQ1 has not been described. Here, we 
identified a protein–protein interaction between the KCNE1 C-terminal domain and the KCNQ1 S6 activation gate 
and S4–S5 linker. Using cysteine cross-linking, we biochemically screened over 300 cysteine pairs in the KCNQ1–
KCNE1 complex and identified three residues in KCNQ1 (H363C, P369C, and I257C) that formed disulfide bonds 
with cysteine residues in the KCNE1 C-terminal domain. Statistical analysis of cross-link efficiency showed that 
H363C preferentially reacted with KCNE1 residues H73C, S74C, and D76C, whereas P369C showed preference for 
only D76C. Electrophysiological investigation of the mutant K
+ channel complexes revealed that the KCNQ1 resi-
due, H363C, formed cross-links not only with KCNE1 subunits, but also with neighboring KCNQ1 subunits in the 
complex. Cross-link formation involving the H363C residue was state dependent, primarily occurring when the 
KCNQ1–KCNE1 complex was closed. Based on these biochemical and electrophysiological data, we generated a 
closed-state model of the KCNQ1–KCNE1 cytoplasmic region where these protein–protein interactions are poised 
to slow activation gate opening.
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below the S6 bundle crossing (H363C and P369C) and 
only one residue in the S4–S5 linker (I257C) that formed 
disulfide bonds with the panel of KCNE1 cysteine mu-
tants. Statistical analysis of cross-link efficiency demon-
strated that H363C preferentially reacted with H73C, 
S74C, and D76C; P369C reacted with D76C only; and 
I257C was the only residue that had widespread reactiv-
ity with the KCNE1 cysteine panel. Functional examina-
tion of H363C showed that disulfide bond formation 
was voltage dependent, occurring predominately when 
the channel was closed, which was due to two factors: 
formation of a disulfide bond with E1 and also with a 
neighboring H363C subunit within the channel com-
plex. Using these experimental constraints, we built a 
closed-state model of the Q1–E1 cytoplasmic region that 
positions the E1 C-terminal domain adjacent to the 
activation  gate  machinery,  which  suggests  that  these 
protein–protein interactions may slow the opening of the 
Q1–E1 complex.
M AT E R I A L S   A N D   M E T H O D S
Plasmids and cDNAs
To create cysteine-less (cys) constructs, wild-type hKCNQ1 and 
hKCNE1 (containing an extracellularly exposed hemagglutinin A 
[HA] tag [YPYDVPDYA]) (Wang and Goldstein, 1995), were mu-
tated by Quikchange (Agilent Technologies) site-directed muta-
genesis and traditional cassette mutagenesis to remove all native 
cysteines. Cysteines were either mutated to serine (aqueous) or 
alanine (membrane embedded) based on a sequence alignment 
with rKv1.2. The cys constructs were subcloned into pcDNA3.1() 
mammalian vectors (Invitrogen). Both cDNAs were fully se-
quenced, and the cysteine-less Q1 channels and Q1–E1 complexes 
were tested for wild-type voltage-dependent gating and inacti-
vation kinetics.
Cell culture and transfections
Chinese hamster ovary (CHO)-K1 cells were cultured in F-12K 
nutrient mixture (Invitrogen) supplemented with 10% fetal bo-
vine serum (Hyclone) and 10
2 U/ml penicillin/streptomycin (In-
vitrogen) and transiently transfected at 70–85% confluency with 
Lipofectamine (Invitrogen) in Opti-MEM (Invitrogen). DNA ratios 
were as follows (in µg): Q1/E1 or Q1-cys/E1-cys (Western blots), 
0.75:1.5; Q1/E1-cys or Q1-cys/E1-cys (electrophysiology), 0.375:3; 
Q1 or Q1-cys alone, or Q1/E1 (electrophysiology), 0.75:1.5. For 
electrophysiology, 0.25 µg of pEGFP-C3 per dish was added. Cells 
were used 48 h after transfection for Western blots and 24–48 h 
after transfection for electrophysiological experiments.
Cross-linking in hypotonically lysed cells
For most of the H2O2-mediated cross-linking experiments, CHO-K1 
cells expressing Q1 and E1 mutants were harvested at 4°C by scrap-
ing in 250 µl/well of hypotonic lysis solution (in mM: 10 KCl, 
1.5 MgCl2, and 10 HEPES, pH 8.0), supplied with protease inhibi-
tors (1 mM PMSF [EM Science] and 1 µg/ml each of leupeptin 
[Roche], pepstatin [Roche], and aprotinin [Sigma-Aldrich]). Mem-
branes were pelleted at 10,000 rpm in microcentrifuge for 10 min, 
resuspended in hypotonic lysis solution, and reduced with 10 mM 
dithiothreitol (DTT) for 10 min. Membranes were then pelleted 
(at 10,000 rpm for 10 min at 4°C), washed once in hypotonic lysis 
solution, resuspended again in hypotonic lysis solution, and oxidized 
Initial electrophysiological studies focused on the mem-
brane-embedded portion of the Q1–E1 complex, and it 
was proposed that the E1 TM segment lined the con-
ductivity pathway (Wang et al., 1996; Tai and Goldstein, 
1998) of the complex. However, the many high resolu-
tion structures of the tightly packed helices of the   
K
+ channel pore domain have made this location infeasi-
ble. More recent electrophysiological investigations have 
relocated the E1 TM on the backside of the Q1 pore do-
main (Tapper and George, 2001; Melman et al., 2004; 
Panaghie et al., 2006). The discovery of atrial fibrilla-
tion mutations in the extracellular S1–S2 loop of Q1 
(Y.H. Chen et al., 2003; Hong et al., 2005; Lundby et al., 
2007) has shifted attention toward the extracellular do-
mains of the Q1–E1 complex. Two different studies using 
cysteine  cross-linking  have  identified  protein–protein 
interactions between the E1 N terminus and the extra-
cellular tops of the S1 and S4 segments, and the pore 
domain of Q1 (Xu et al., 2008; Chung et al., 2009). In 
total, these studies position the E1 TM segment in a cleft 
between the pore and voltage-sensing domains of the 
Q1 channel. A recent coimmunoprecipitation study of 
the cytoplasmic parts of the Q1–E1 complex has identi-
fied a large stretch of residues at the E1 C terminus 
that binds to the subunit identification (“tetrameriza-
tion”) domain of the Q1 channel, providing an anchoring 
point at the C terminus (Haitin et al., 2009).
A cytoplasmic domain of E1 that has been of contin-
ual interest comprises the 20 residues that abut the 
membrane, which are seemingly ideally located near the 
cytoplasmic machinery of Q1 responsible for voltage-
dependent gating. One of the first mutagenesis investiga-
tions of E1 (then IKs) showed that point mutations in 
this C-terminal domain greatly affect channel activity 
(Takumi et al., 1991). Subsequent deletion and chimera 
studies have indicated that this domain is critical for the 
characteristic slow activation kinetics of the Q1–E1 com-
plex (Tapper and George, 2000; Gage and Kobertz, 2004). 
Moreover, several missense point mutants that cause long 
QT syndrome cluster to this C-terminal domain in E1 
(Splawski et al., 2000; Schulze-Bahr et al., 2001; Ma et al., 
2003; Lai et al., 2005; Napolitano et al., 2005). Periodicity 
analysis of mutagenic perturbation experiments have 
shown that this membrane-abutting domain of E1 adopts 
an -helical structure when split in half at a conserved 
proline residue (Rocheleau et al., 2006). This secondary 
structure predicts that all of the known long QT muta-
tions in this domain will face the Q1 channel. Despite the 
extensive study by several laboratories, the protein–pro-
tein interactions between the E1 C-terminal domain and 
Q1 have remained uninvestigated.
To identify the Q1 cytoplasmic surfaces that interact 
with the E1 C-terminal domain, we used oxidant-mediated 
disulfide bond formation between exogenous cysteine 
point mutations in a cysteine-null background (Schulteis 
et al., 1996; Kobertz et al., 2000). We found two residues   Lvov et al. 609
bond formation was monitored by holding cells at 80 mV and 
recording the average current during a 40-ms window at the end 
of a 20-mV, 3-s test depolarization taken every 15 s. To measure 
the rate of disulfide bond formation primarily in the closed state, 
the 3-s test depolarizations were taken every 100 s (instead of 15 s) 
and compared with the standard protocol. In contrast, open-state 
oxidation was analyzed using three consecutive 90-s test depolar-
izations spaced by 100 s at the holding potential (80 mV);   
recording solution containing 0.1% H2O2 was started at the be-
ginning of either the first inter pulse interval or the second depo-
larizing pulse.
Data analysis (biochemistry)
Absorbance data for each Western blot was collected using a CCD 
camera in the linear range, corrected for background noise, and 
normalized using the equation:
  y
abs
abs abs
=
+ −
150
150 37 50
kD
kD kD
. 
To quantitate the array of bands at 37–50 kD, we measured the entire 
signal in this range for each sample and subtracted the background 
intensity from a negative control lane. The normalized absorbance 
was then plotted as a function of the position of each cysteine 
mutation (or lack of cysteine mutation) in KCNE1 using Origin 6 
software (OriginLab). Statistical significance was determined in two 
steps. A model of all absorbance data was calculated, and model 
residuals were collected. The natural logarithm of the calculated 
residuals fit well to a normal distribution (the Kolmogorov-Smirnov 
Z value was reduced twofold by taking the natural logarithm,   
Z ≈ 1.6). The natural logarithm of each normalized absorbance was 
subsequently used in a general linear mixed model (Tukey-Kramer) 
to determine an adjusted p-value. Each experimental set was tested 
against three negative controls (cross-link between E1 cysteine point 
mutations and two non-labile cysteine point mutations in Q1 and 
an internal negative control in each dataset: E1-cys cross-linked 
with cysteine point mutations in Q1). Only those experimental 
datasets displaying an adjusted P < 0.05 for all three negative con-
trols are labeled. These data are binned according to the least sig-
nificant p-value.
Data analysis (electrophysiology)
Current normalized to pre-oxidant levels was plotted against time. 
The resultant time courses of oxidant-induced current reduction 
fit well to single –exponential decay.
Online supplemental material
Fig. S1 contains the quantification of the biochemical cross-
linking for all of the Q1–E1 cysteine pairs that were not statisti-
cally significant. Fig. S2 compares the oxidation-induced current 
reduction of H363C to Q1-cys, P369C, and I257C, which were 
relatively unaffected by oxidant. Fig. S3 A shows that Q1–Q1 
cross-link formation with the panel of Q1 mutants was minimal 
compared with H363C. Fig. S3 B confirms that Q1–E1 cross-
link formation occurs at the plasma membrane and was reversible   
by reductant. Figs. S1–S3 are available at http://www.jgp.org/ 
cgi/content/full/jgp.200910386/DC1.
R E S U LT S
To biochemically screen the cytoplasmic Q1 residues 
against residues in the E1 C-terminal domain by disulfide 
cross-linking (Fig. 1 A), we first removed the native cyste-
ines from the complex because mild oxidation of wild-type 
with a total of 0.01% H2O2 for 10 min at room temperature. 
Unoxidized cysteines were quenched with 30 mM N-ethyl ma-
leimide at room temperature for 1 h. Membranes were once 
again pelleted (at 10,000 rpm for 10 min at 4°C), removing the 
supernatant, and solubilized by rolling for 30 min at 4°C in 1.5% 
digitonin (EMD) solution (in mM: 290 NaCl, 10 KCl, 1 MgCl2, 7 Tris, 
pH 7.5, and 1.5% digitonin, supplied with protease inhibitors). 
Proteins were resolved by nonreducing SDS-PAGE and subjected 
to Western blot analysis. For Q1–Q1 cross-linking experiments, 
the samples were oxidized with 0.1% H2O2, which was the con-
centration used in electrical recordings. In addition, disulfide 
bond formation was confirmed by reduction with 50 mM tris(2-
carboxyethyl)phosphine for 30 min at 37°C. For the cross-linking 
of  the  cell  surface  labeling  proteins,  harvest,  oxidation,  and 
quench of the membrane proteins were performed as explained 
above, except that before the cell lysis, their surfaces were biotin-
ylated with EZ-Link sulfo-NHS-SS-biotin (Thermo Fisher Scien-
tific) as described previously (Chandrasekhar et al., 2006).
Coimmunoprecipitation
Harvest, oxidation, and quench of membrane proteins proceeded 
exactly as described above, except that samples were oxidized 
with a total of 0.1% H2O2. After quenching, membranes were 
solubilized in RIPKA (in mM: 140 NaCl, 10 KCl, 1% Triton X-100, 
0.1% SDS, 1% sodium deoxycholate, 10 Tris-HCl, pH 7.4, and 
1 EDTA, pH 8.0, supplied with protease inhibitors, by rolling for 
30 min at 4°C). Solubilized proteins were then diluted with 10% 
(vol/vol) 500 mM Na3PO4, pH 7.5, and deglycosylated with 1% 
peptide N-glycosidase F (PNGase F; New England Biolabs, Inc.) or 
mock treated for 1 h at 37°C. After deglycosylation, samples were 
incubated rolling with 7.1% (vol/vol) -Q1 (Santa Cruz Bio-
technology, Inc.) overnight at 4°C. Antibody was then bound to 
immobilized protein G beads (Thermo Fisher Scientific), washed 
three times with RIPKA, and eluted from beads using a DTT elu-
tion solution (in mM: 140 NaCl, 10 Tris, pH 7.4, 1 EDTA, pH 8.0, 
100 DTT, and 1% SDS). Finally, the immunoprecipitated samples 
were resolved by SDS-PAGE, and then subjected to immunoblot-
ting analysis with rat -HA (Roche) antibody.
Perforated patch whole cell recordings
Currents were recorded in the standard whole cell perforated 
patch configuration at room temperature (24 ± 2°C). In brief, on 
the day of the experiment cells were seeded on the surface of 
cover glass and placed to a custom recording bath filled with a 
modified Tyrode’s solution, which contained (in mM): 145 NaCl, 
5.4 KCl, 10 HEPES, and 5 CaCl2, pH 7.5 with NaOH. Transfected 
(eGFP-expressing) cells were selected using an inverted light micro-
scope (Axiovert 40 CFL; Carl Zeiss, Inc.). For the perforated patch 
configuration, a glass electrode (pipette resistance: 2.5–3.5 MΩ) 
was filled with electrode solution (in mM: 126 KCl, 1 MgSO2, 
0.5 CaCl2, 5 EGTA, 4 K2-ATP, 0.4 GTP, and 25 HEPES, pH 7.5 with 
CsOH),  and  60  µg/ml  amphotericin  B  (prepared  in  DMSO; 
Sigma-Aldrich) was attached to the cell. Once a GΩ seal was 
achieved and access resistance was dropped to the sufficient level 
to record membrane potential (<10 MΩ), Tyrode’s solution was 
replaced with the extracellular bath solution, which contained (in 
mM): 160 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 8 glucose, and 10 HEPES, 
pH 7.5 with NaOH. Initially, the electrical access to the inside of 
the cell was monitored using a 3-s depolarizing test pulse from the 
holding potential of 80 to +20 mV taken every 15 s. Prediction, 
correction, and leak subtraction were not used in any recordings; 
cells with pronounced rundown were discarded, and only record-
ings with stable currents were used. Wild-type and cysteine-less 
Q1 and IKs were assayed for native function using a “family” pro-
tocol, in which cells held at 80 mV were stepped every 15 s to 
potentials between 100 and +60 mV in 20-mV increments for 
3 s, followed by a 1-s tail pulse to 30 mV. H2O2-mediated disulfide 610 Cytoplasmic Q1/E1 protein–protein interactions
these subtle differences, the cysteine-less Q1–E1 complex 
generated the characteristic cardiac IKs current, indicating 
that the complex possessed a native-like structure, which 
we subsequently probed with disulfide cross-linking.
Disulfide bonds form between cysteine residues in the E1 
C-terminal domain and the Q1 activation gate machinery
Based on the proposed propinquity of the E1 TM domain 
and pore domain, we first targeted Q1 residues (342–371), 
starting at the putative bundle crossing (“PAG”) of the S6 
activation gate (Seebohm et al., 2006) and ending before 
the calmodulin binding motif (Shamgar et al., 2006). Be-
cause of the dynamic nature of the channel’s gate, we did 
not expect to reveal discrete interactions between amino 
acid side chains, but rather swathes of E1 cross-linking at 
certain Q1 residues. The residues in this region were indi-
vidually mutated to cysteine and separately coexpressed 
with the panel of E1 C-terminal cysteine mutants (70–82). 
After 48 h of expression in CHO cells, the reducing intra-
cellular environment was removed by hypotonic lysis, and 
the lysate was oxidized with hydrogen peroxide (0.01%) 
for 10 min. The quenched cell lysates were detergent solu-
bilized, and the proteins were resolved by nonreducing 
SDS-PAGE. Fig. 2 A shows representative E1 Western blots 
from three Q1 activation gate cysteine mutants. On these 
low percentage polyacrylamide gels, several bands corre-
sponded to monomeric E1. E1 protein with immature 
N-linked glycans migrated as a single band at the bottom 
of the gel, whereas the heterogeneity of the maturely gly-
cosylated E1 protein was resolved as multiple bands be-
tween 37 and 50 kD. These bands were not due to E1–E1 
cross-links because they were also present in the cysteine-
less construct (() lane) and in unoxidized samples (not 
depicted). Although this banding pattern was unaesthetic, 
it demonstrated that the Q1 and E1 mutants efficiently 
formed complexes because unpartnered E1 subunits pri-
marily reside in the endoplasmic reticulum with immature 
glycans (Chandrasekhar et al., 2006). For the H363C and 
P369C mutants, several other E1-containing species were 
observed with masses between 50 and 150 kD. Of these 
higher molecular weight species, the most intense band 
migrating just below the 150-kD marker had character-
istics that were indicative of a cross-link between Q1 and 
E1; this band required a cysteine in E1, and its intensity 
was dependent on the position of the cysteine residue.
The intensity of the 150-kD band was normalized (to 
the total maturely N-glycosylated E1) and plotted for each 
E1 residue (Fig. 2 B). As was evident from the blots, the 
A370C mutant did not significantly react with any residues 
in the panel of E1 cysteine mutants, whereas the H363C 
and P369C mutants yielded significant cross-linked mate-
rial when compared with cysteine-less E1 control (() 
lane). Of all the Q1 cysteine mutants screened (Fig. S1), 
H363C and P369C were the only two mutants that afforded 
>20% cross-linking of maturely glycosylated E1 protein. 
Q1–E1 resulted in higher molecular weight cross-linked 
species (not depicted). Transient transfection of these 
cysteine-less versions (Q1-cys and E1-cys) into CHO cells 
gave rise to currents (Fig. 1 B) with wild-type gating kinet-
ics for both Q1 (fast activation and voltage-dependent in-
activation) and Q1–E1 (slow activation/deactivation with 
no observable inactivation). The cysteine-less Q1–E1 com-
plex did have three behaviors that were of note: (1) the 
voltage sensitivity of the complex was slightly left-shifted 
compared with wild type; (2) current expression was more 
robust compared with wild type; and (3) the current re-
cordings were not stable in the whole cell patch config-
uration and required the use of the perforated patch 
technique (see Materials and methods). Notwithstanding 
Figure 1.  TM topology diagram of the Q1–E1 channel complex 
highlighting (with yellow) the residues within the juxtamembranous 
C-terminal domain of E1 and the cytoplasmic face of the Q1 pore 
domain examined with cysteine cross-linking. (A) For the clarity, 
only two subunits of the Q1 tetramer are shown. Voltage-sensing and 
pore-forming domains, and the S4–S5 linker are colored red, blue, 
and cyan, respectively; E1 is colored green. (B) Cysteine-less Q1 and 
E1 subunits (cys) give rise to native-like currents. Representa-
tive whole cell currents recorded from CHO-K1 cells transiently 
transfected with Q1-cys alone (left) or E1-cys (right). Dashed line 
indicates 0 net current. (Inset) Voltage pulse protocol used to elicit 
the currents. Membranes were held at 80 mV and stepped to 
potentials between 100 and +60 mV in 20-mV increments for 
3 s; interpulse duration was 15 s.  Lvov et al. 611
the panoply of other bands remained in the supernatant. 
Elution of the disulfide-bound proteins with DTT only 
produced an E1 signal when both cysteine residues 
were present in the Q1–E1 complex. Moreover, PNGase F 
treatment identified the eluted E1 protein as maturely   
N-glycosylated, indicating that the cross-linked Q1–E1 
complexes were properly folded because they passed the 
quality control  machinery  in  the  endoplasmic  reticu-
lum. Thus, the results in Fig. 3 B identify the cross-linked 
species at 150 kD as disulfide-bonded Q1–E1 hetero-
dimers with mature N-linked glycosylation and demon-
strate that the E1 C-terminal domain interacts with two 
residues (H363 and P369) below the S6 activation gate.
Because the S4–S5 linker of Q1 communicates volt-
age sensor movement to the S6 activation gate opening, 
we next probed this Q1 cytoplasmic linker for interac-
tions with the E1 C-terminal domain. Using our initial 
oxidation conditions (0.01% H2O2), we observed little 
to  no  cross-linking  between  the  S4  and  S5  residues 
(251–257) and the E1 C-terminal domain (not depicted). 
However, increasing the concentration fivefold resulted 
in broad-spectrum cross-linking between I257C and the 
panel of E1 cysteine mutants (Fig. 4). Cross-linking was 
specific for I257C because the other cysteine mutants in 
the S4–S5 linker remained unreactive with the increase 
in oxidant concentration (Fig. S1 B).
Statistical analysis of the reactive E1 cysteine residues re-
vealed  that  H73C,  S74C,  and  D76C  were  significantly 
more reactive with H363C; and D76C with P369C.
Having found these putative cross-linked species, 
we sought to determine whether they were composed   
of a disulfide-bonded Q1–E1 heterodimer. Because 
Q1–Q1 homodimers (vide infra) have similar mobil-
ity on SDS-PAGE, we used denaturing coimmunopre-
cipitation (Fig. 3 A) to identify the proteins in the cross-link 
and to determine whether they were covalently attached 
via a disulfide bond. In this approach, the oxidized cell 
ghosts were dissolved in SDS to denature the Q1–E1 com-
plexes, and the detergent-solubilized Q1 protein was 
quantitatively immunoprecipitated (Fig. 3, Q1 blot). Un-
der these denaturing conditions, only E1 protein cova-
lently attached to Q1 subunits will precipitate and be 
removed from the supernatant. Mild DTT treatment of 
the immunoprecipitated material selectively breaks the 
disulfide bond, eluting any covalently attached E1 sub-
units from bead-bound Q1 subunits. Fig. 3 B shows the 
results from a denaturing immunoprecipitation between 
H363C and S74C and D76C. The oxidized input lanes 
show that the intensity of the band at 150 kD was highly 
dependent on both subunits containing a cysteine. Dena-
turing immunoprecipitation of the Q1 subunits selec-
tively precipitated the two intense 150-kD bands, but 
Figure 2.  Two Q1 cysteine mutants, H363C and P369C, near the S6 activation gate form higher molecular weight species with a panel of 
single-cysteine E1 mutants. (A) Western blots from hypotonically lysed CHO cells oxidized with 0.01% H2O2 for 10 min. Proteins were resolved 
on nonreducing SDS-PAGE and immunoblotted for E1. All single-cysteine E1 mutants produce a series of bands between 37 and 50 kD, which 
corresponded to maturely N-glycosylated E1 peptides; immaturely N-glycosylated E1 is located at the bottom of the blots. Oxidation results in 
several higher molecular weight species between 50 and 150 kD, with an intense band just below 150 kD (dotted box). The strength of this 
band varies depending on the identity of the cross-link pairing. Molecular weight and monomeric glycoforms of E1 are denoted. (B) Normal-
ized signal intensity of the 150-kD Q1–E1 band plotted against the position of the cysteine in E1 for the single-cysteine Q1 mutants showed in 
A. Signal denotes the mean for n = 3–4 experiments ± SEM. Asterisks indicate significance of at least P < 0.01. The dashed line is shown because 
cross-linking >20% was determined to be statistically significant.612 Cytoplasmic Q1/E1 protein–protein interactions
determined how oxidation of these complexes would 
affect function. The different Q1–E1 cysteine pairs were 
first expressed in CHO cells, and whole cell currents 
were elicited with a 3-s depolarizing test pulse to +20 mV. 
Current for all Q1–E1 cysteine pairings exhibited the 
slow gating kinetics of IKs and lacked any signs of inacti-
vation, indicating that the mutant subunits properly 
coassembled (Fig. 5 A and Fig. S2). Oxidative treatment 
of H363C paired with the more biochemically reactive 
E1 mutants H73C, S74C, or D76C resulted in 80–90% 
reduction of current within 5 min (Fig. 5 A, top row). In 
contrast, the currents from P369C and I257C coex-
pressed with D76C were relatively unaffected by oxidant 
(Fig. S2, C–F). Further functional examination of H363C 
revealed that oxidation reduced the currents regardless 
of the position of the cysteine in E1 (Fig. S2). Because 
the single cysteines in E1 expressed with cysteine-less Q1 
(Q1-cys) were minimally affected by oxidant (Fig. 5 A, 
middle row), we suspected that the oxidant was induc-
ing Q1 subunit homodimerization via the H363C resi-
due. Oxidation of H363C expressed with cysteine-less 
E1 (E1-cys) resulted in 50% reduction of current, which 
was significant compared with the cysteine-less Q1–E1 
complex (Fig. 5 A, bottom row). A comparison of the 
mutant Q1–E1 complexes (Fig. 5 B) clearly showed that 
oxidation of H363C was a major contributor to current 
loss; however, the inclusion of E1 cysteine mutants at 
positions 73, 74, or 76 also contributed to current re-
duction. Attempts to reverse the oxidant-induced cur-
rent inhibition by treating the cells with 2–5 mM DTT 
consistently resulted in loss of the gigaohm seal within 
30 s of application (not depicted). Thus, in functional 
assays, it was unclear whether a disulfide bond was form-
ing between Q1 subunits.
To directly test for Q1–Q1 disulfide bond formation, 
we revisited the H363C mutant in biochemical assays 
(Fig. 5 C). Oxidation of hypotonically lysed cells ex-
pressing the cysteine-less Q1–E1 construct afforded 
primarily monomeric Q1 protein on Western blots, al-
though a faint band migrating at the predicted dimer 
size was always discernable. In contrast, a strong band 
was observed when H363C was coexpressed with ei-
ther D76C or E1-cys, demonstrating that Q1–Q1 di-
mers were forming in the absence of a cysteine in the   
E1 subunit. Treatment of the oxidized samples with 
reductant collapsed the cysteine-specific Q1–Q1 dimer 
band into a monomer (Fig. 5 C, right), which identi-
fied this band as a disulfide bonded Q1 homodimer. 
Robust disulfide bond formation between Q1 subunits 
was only observed for H363C, although weaker Q1–Q1 
cross-linking was observed for the residues adjacent to 
H363C (Fig. S3 A).
State-dependent cross-linking of Q1–E1 complexes
Because the H363C mutant mediated Q1–Q1 homodi-
merization, we next determined whether the cross-link 
Functional consequences of disulfide formation in the Q1 
activation gate machinery and E1 C-terminal domain
After identifying pairs of Q1–E1 cysteine mutants that 
formed disulfide bonds in biochemical experiments, we 
Figure 3.  The 150-kD species are Q1–E1 disulfide-bound hetero-
dimers. (A) Cartoon depiction of the strategy used to verify the 
protein  cross-link  of  the  150-kD  band.  Membrane-embedded 
proteins were oxidized with 0.1% H2O2 for 10 min, dissolved in 
detergent, and immunoprecipitated with anti-Q1 antibodies. Elu-
tion with DTT releases the E1 subunits covalently attached to 
Q1 subunits via a disulfide bond. (B) Western blots from a denatur-
ing coimmunoprecipitation of oxidized Q1–E1 complexes. (Left) 
Inputs and supernatants from oxidized whole cell CHO lysates 
were probed with E1 (top) or Q1 (bottom) Western blot. The 
protein loaded for each Q1–E1 pairing was kept constant. Cys-
teine mutants are denoted above blot: , cysteine-less subunit; 
Ø, nontransfected cells. Molecular weight markers are shown on 
the left. E1 blot demonstrates that immunoprecipitation of Q1 re-
moves the 150-kD band on the E1 blot only when both subunits 
contain a cysteine (363/74 and 363/76). The Q1 blot shows the ef-
ficacy of immunoprecipitation; quantization of the bands showed 
that >95% of Q1 protein was immunoprecipitated. (Right) DTT 
elution releases E1 subunits from the immunoprecipitated Q1–E1 
complexes only when there is a cysteine in each subunit. The ma-
turely heteroglycosylated E1 proteins run as a smear at 37 kD 
(Chandrasekhar et al., 2006). Mature N-linked glycans were re-
moved with PNGase F treatment (+).  Lvov et al. 613
of a cysteine in E1 (D76C) appears to enhance cross-
link formation.
Although both the H363C–E1-cys and H363C–D76C 
complexes efficiently formed cross-links in the closed 
state, the previous rate comparison experiments did not 
rule out the possibility that the reaction could also occur 
in the open state. To directly test for open-state cross-link-
ing, we took advantage of one of the unique properties of 
the Q1–E1 complex: the complex does not inactivate with 
prolonged depolarizations (minutes) (Tzounopoulos 
et al., 1998). On this time scale, it was feasible to apply 
oxidant to a whole cell during a depolarization versus at 
rest. Because depolarizing a cell on the minute times-
cale is a bit unorthodox, we first determined whether 
we could repetitively depolarize the same cell for 90 s 
and reproducibly acquire Q1–E1 currents. The black 
current traces in Fig. 6 B show that three sequential 90-s 
depolarizations elicited relatively stable currents from 
the H363C–D76C complex. The application of oxidant 
during the first inter-depolarization interval (Fig. 6 B, 
blue data) resulted in a reduction of current in the sub-
sequent depolarization, confirming the closed-state cross-
linking in Fig. 6 A. However, the application of oxidant 
at the start of the second depolarization (Fig. 6 B, red 
data) had little to no effect on the magnitude of the end-
ing current, indicating that neither the H363C–H363C 
nor the H363–D76C cross-link appreciably forms in the 
open state. As expected, closing the channel complex after 
the second depolarization resulted in rapid cross-link 
formation that was visualized in the third and final depo-
larization (Fig. 6, B and C). In total, these state-dependent 
experiments  established  that  both  H363C–H363C  and 
H363–D76C cross-link formation predominately occurs 
when the complex is closed.
D I S C U S S I O N
Previous Q1–E1 cysteine cross-linking studies have fo-
cused on extracellular protein–protein interactions 
in intact cells, where the environment is oxidizing and 
the membrane potential of the cell provides control 
of complex conformation. In the present work, we fo-
cused on the juxtamembranous part of the E1 C terminus 
because this domain adopts a helical structure, where 
both laboratory-made and long QT mutations cluster 
to one face of the helix predicted to face the cytoplas-
mic side of the Q1 channel (Rocheleau et al., 2006). To 
identify these Q1–E1 protein interactions, we oxidized 
hypotonically lysed cells, which provided cytoplasmic 
access to the complex in a membranous environment. 
Although these conditions enabled us to screen hun-
dreds of pairs of Q1–E1 residues, our approach comes 
with a caveat: hypotonic lysis destroys the electrochemi-
cal gradient and TM potential. Thus, at 0 mV the acti-
vation gate machinery of the channel is predicted to 
be undergoing large movements while equilibrating 
formed in the open and/or closed state. To examine 
cross-linking  primarily  in  the  closed  state,  we  com-
pared the rates of oxidant-induced current reduction 
using two protocols that varied the time spent at de-
polarizing potentials. The first protocol was our stan-
dard protocol, where the cell was depolarized 20% of 
the time (Fig. 6, inset). The second protocol maxi-
mized the time the cell was held at rest with only brief, 
+20-mV sojourns to measure the effect of oxidant ap-
plication (Fig. 6, filled circles). Fig. 6 A shows that 
rates of oxidized-induced current reduction of H363C 
were similar regardless of the protocol used. Minimiz-
ing the number of depolarizations with D76C in the 
complex had no affect on the rate of current reduc-
tion, although its presence did modestly accelerate 
the rate of current reduction compared with H363C 
alone (50 ± 10 s vs. 64 ± 16 s). Thus, H363C homodi-
merization occurs in the closed state, and inclusion   
Figure 4.  A cysteine mutant (I257C) in the S4–S5 forms cross-links 
with the panel of E1 cysteine mutants. (A) Western blots from hypo-
tonically lysed CHO cells oxidized with 0.05% H2O2 for 10 min. 
Proteins were resolved on nonreducing SDS-PAGE and immuno-
blotted for E1. Oxidation results in several higher molecular weight 
species between 50 and 150 kD, with the previously identified Q1–E1 
cross-link just below 150 kD (dotted box). The strength of this 
band was again dependent on the cross-link pairing. Molecular 
weight markers are denoted. (B) Normalized signal intensity of 
the 150-kD species formed by I257C with a panel of E1 mutants. 
Bars denote the mean for six experiments ± SEM. Asterisks indicate 
significance of at least P < 0.05. The dashed line is shown because 
cross-linking >20% was determined to be statistically significant.614 Cytoplasmic Q1/E1 protein–protein interactions
perturbations of Q1–E1 complex function (Rocheleau 
et al., 2006), these three residues are predicted to 
face the Q1 channel. Although not statistically signifi-
cant, visual inspection of the biochemical reactivity of 
the E1 cysteine mutants uncannily mirrors the previ-
ously studied functionally disruptive alanine mutants: 
73, 74, 76, 78, 81, and 82. Given that the cross-linked 
Q1–E1 subunits arose from Q1–E1 complexes that were 
properly  folded  (presence  of  mature  glycosylation; 
Figs. 2–4) with IKs kinetics (Fig. 5 A and Fig. S2), and 
at the cell surface (Fig. S3 B), we conclude that these 
mutant Q1–E1 complexes have maintained their wild-
type structure. Thus, our data show that the E1 C-termi-
nal domain forms a protein–protein interaction with 
between open and closed states. Moreover, there is 
evidence that the E1 TM domain rotates during gating 
(Xu et al., 2008; Chung et al., 2009), which if propa-
gated to the C terminus would also promote wide-
spread cross-linking. Accordingly, the reactive Q1 cysteine 
mutants identified here form cross-links with most of 
the E1 cysteine mutants studied. In spite of this caveat, 
we were able to identify three residues in Q1 (H363C, 
P369C, and I257C) that readily formed disulfide bonds 
with cysteine residues in the E1 C-terminal domain (Figs. 2 
and 4). Statistical analysis demonstrated that there was 
some selectivity for certain E1 residues: H363C with 
H73C, S74C, and D76C; P369C with D76C. Based on 
a  previous  periodicity  analysis  of  mutation-induced 
Figure 5.  Oxidant-mediated cross-linking at H363C results in a disulfide bond between adjacent Q1 subunits. (A) Whole cell currents 
observed in CHO cells for (top) H363C with three E1 cysteine mutants, (middle) Q1-cys with three E1 cysteine mutants, and (bottom) H363C 
with E1-cys and the cysteine-less complex (Q1-cys+E1-cys). Black traces are before oxidation, and red traces are after a 5-min treatment 
with oxidant (0.1% H2O2). Currents were elicited by a 3-s depolarizing step from the holding potential of 80 to +20 mV with a 12-s interpulse 
interval. 0 current is labeled with a triangle, and the scale bar denotes 1 s. (B) Normalized oxidant-induced current reduction of the 
panel of Q1–E1 cysteine mutants. Currents measured before and after the oxidation were normalized and plotted as mean ± SEM; n = 3–6 
samples per pairing. (C) H363C forms Q1–Q1 homodimers in the presence or absence of an E1 cysteine residue. CHO cells expressing 
the different Q1–E1 complexes were lysed, treated with peroxide, separated on nonreducing SDS-PAGE, and subjected to Western blot 
analysis using anti-Q1 antibodies. A band corresponding to a covalent dimer of H363C subunits was observed with or without D76C in the com-
plex (left). The dimeric entities could be disassembled into monomer by reduction with tris(2-carboxyethyl)phosphine (TCEP; right).  Lvov et al. 615
of  the  complex,  and  thus  function  is  unaffected.  A 
similar functionally non-disruptive cross-link hypothe-
sis has been proposed for extracellular biochemical 
cross-links that do not perturb Q1–E1 function (Chung 
et al., 2009).
In contrast to P369C and I257C, we observed rapid 
loss of function when H363C was in the Q1–E1 complex. 
However, the extent of oxidant-induced current inhibi-
tion for H363C was similar for all of the E1 cysteine 
mutants—even for residues that showed minimal reactivity 
in biochemical experiments (Fig. 5 and Fig. S2 A). This 
across the board loss of function suggested that H363C 
was forming an inter Q1 subunit cross-link, which we 
confirmed with the H363C–E1-cys complex in electrical 
Q1 residues below the S6 activation gate and in the 
S4–S5 linker.
Surprisingly, oxidation of two of the biochemically 
reactive Q1 cysteine residues (P369C and I257C) in 
whole  cell  recordings  had  no  measurable  effect  on 
Q1–E1 complex function when paired with a reactive 
E1 cysteine mutant (Fig. S2, C–F). Lack of functional 
phenotype for these two Q1 mutants may be due to di-
minished reactivity of peroxide in the reducing envi-
ronment of the cell, even though we increased the 
concentration  10-fold  for  these  intact  cell  experi-
ments. It is also possible that these two Q1 residues are 
indeed forming a cross-link with the E1 subunit, but 
the disulfide bond does not hinder the voltage gating 
Figure 6.  Q1–Q1 cross-link formation via H363C predominately occurs in the closed state. (A) Change in current monitored over time 
using +20-mV test pulses with a different interpulse duration, as shown in inset. Open circles represent the “open-state” protocol, where 
channels were depolarized 20% of total time (3-s pulse every 15 s), and filled circles are for “closed-state” protocol, where channels were 
depolarized 4% of total time (3-s pulse every 100 s). Recordings are from CHO cells expressing H363C with either E1-cys or D76C. 
Clamped cells exhibiting stable currents were exposed to perfusion of 0.1% H2O2, as shown in the inset. Data points are mean ± SEM 
(n = 3). Time constants of oxidant-induced inhibition: H363C alone, 64 ± 16 s; H363C/D76C, 50 ± 10 s. (B) Application of oxidant to 
complexes at resting and depolarizing potentials. Currents were elicited using 90-s depolarizing pulses to +20 mV separated by 100-s 
interpulse intervals at a resting potential of 80 mV. Hydrogen peroxide (0.1%) was applied at either the start of the first interpulse 
interval (blue) or the beginning of the second depolarizing test pulse (blue). Control traces (no peroxide applied) are shown in black. 
Oxidation during an interpulse interval results in an immediate loss of current, whereas oxidation at depolarizing potential (+20 mV) 
for the same duration has little to no effect on the magnitude of the current measured at the end of the depolarization. (C) Reduction 
of current over time for the different oxidation conditions. Current values were measured at the end of each +20-mV test pulse and are 
plotted as mean ± SEM (n = 3).616 Cytoplasmic Q1/E1 protein–protein interactions
clude any imposition of van der Waals volumes. Only 
one of the two E1 subunits is shown in Fig. 7 (H. Chen 
et  al.,  2003;  Morin  and  Kobertz,  2008).  The  model 
provocatively  intimates  that  the  E1  C-terminal  do-
mains may encumber the Q1 activation gate machin-
ery, slowing down the transition from closed to open 
and leading to the generation of the cardiac IKs cur-
rent. If our model is operational, the slowed activa-
tion of Q1–E1 complexes could arise from either the 
specific Q1–E1 interactions identified here, or by non-
specific obstruction of activation gate opening by the E1 
C terminus.
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recordings and nonreducing SDS-PAGE (Fig. 5). Although 
the Q1–Q1 cross-link accounted for most of the cur-
rent inhibition observed with H363C, inclusion of cer-
tain E1 cysteine mutants in the complex increased the 
amount of oxidized-induced current inhibition (Fig. 5 
and Fig. S2 A). Whether this additional reduction of 
current is due to a direct Q1–E1 cross-link (as was ob-
served in biochemical experiments) or an E1 cysteine–
mediated acceleration of Q1–Q1 cross-link formation 
is uncertain. Nonetheless, either mechanism requires 
the E1 cysteine residue to be spatially close to the 
H363C residue.
Because oxidation-induced inhibition of H363C could 
be monitored in whole cell recordings, we compared 
the  rates  of  inhibition  using  two  different  voltage 
pulse protocols to determine whether cross-link for-
mation was occurring in a state-dependent manner 
(Fig. 6). By exploiting the unusual gating kinetics of 
the Q1–E1 complex (slow activation and lack of inac-
tivation at depolarizing potentials), we showed in intact 
cells that H363C predominately formed a cross-link 
in the closed state. Inclusion of a cross-linkable cyste-
ine in E1 (D76C) into the complex did not change 
the state dependency of oxidant-induced inhibition of 
H363C. Thus, from these state-dependent experiments, 
we  conclude  that  the  H363C  residues  are  adjacent   
to each other when the Q1 activation gate is closed, 
and D76 in E1 is also near the cytoplasmic gate in the 
closed state.
Using these experimental results, we generated a closed-
state model of the Q1–E1 cytoplasmic region (Fig. 7). 
We fashioned our model from the predicted three- 
dimensional structural model of the human Q1 channel 
in the closed conformation (Smith et al., 2007) and 
the NMR structure of E1 TM domain reconstituted   
in lyso-myristoylphosphatidylglycerol micelles (Kang 
et al., 2008). Unfortunately, neither structure possesses 
the data to model the Q1 and E1 cytoplasmic domains 
in their native conformation. Therefore, we propa-
gated the TM helices of Q1 and E1 until we reached 
beyond the regions of interest. For the juxtamembra-
nous part of the E1 C terminus, we chose to introduce 
a kink at E1 residue P77 because we have previously 
shown that this domain is either a proline-kinked helix 
or a helix that experiences two different protein–pro-
tein interactions (Rocheleau et al., 2006). To create 
the model of the Q1–E1 cytoplasmic region, we posi-
tioned the E1 C-terminal domain adjacent to the Q1 
activation gate machinery, such that D76C, the most 
reactive E1 residue, was centrally located while keep-
ing the E1 TM domain close to the S6, S1, and S4 heli-
ces of Q1 (Xu et al., 2008; Chung et al., 2009). Because 
the cytoplasmic domains are not based on crystallo-
graphic data or NMR restraints, no computer simula-
tions or docking were used; however, a visual inspection 
of the superimposed structures was performed to ex-
Figure 7.  Cartoon model depicting the cytoplasmic interactions 
of the E1 C-terminal domain and the Q1 activation gate machinery. 
(Inset) Magnification of the region of interest depicting the resi-
dues identified by cysteine cross-linking. Q1 subunits are gray, 
E1 subunit is blue, and the indentified residues are red and ren-
dered as space-fill.  Lvov et al. 617
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